↓ Skip to main content

Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles

Overview of attention for article published in Molecular Therapy, July 2025
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
8 X users
bluesky
2 Bluesky users

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles
Published in
Molecular Therapy, July 2025
DOI 10.1016/j.ymthe.2025.07.014
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 1 11%
Other 1 11%
Unknown 7 78%
Readers by discipline
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Business, Management and Accounting 1 11%
Immunology and Microbiology 1 11%
Unknown 6 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2025.
All research outputs
#10,056,652
of 30,082,547 outputs
Outputs from Molecular Therapy
#3,319
of 5,927 outputs
Outputs of similar age
#94,310
of 321,700 outputs
Outputs of similar age from Molecular Therapy
#31
of 133 outputs
Altmetric has tracked 30,082,547 research outputs across all sources so far. This one has received more attention than most of these and is in the 65th percentile.
So far Altmetric has tracked 5,927 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 321,700 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.